A Promising Way To Treat Specific Lymphoma

A Promising Way To Treat Specific Lymphoma.
Researchers have identified a gene metamorphosing that may sell a target for new treatments for a type of lymphoma. The yoke found that a mutation of the MYD88 gene is one of the most frequent genetic abnormalities in patients with this cancer, known as wide B cell lymphoma lemonade. The MYD88 gene encodes a protein that is crucial for orthodox immune response to invading microorganisms.

The mutation identified in this study can cause uncontrolled cellular signaling, resulting in the survival of life-threatening cells gambar. A subgroup of the large B cell lymphoma that has a dismally stifled cure rate - known as the activated B cell-like (ABC) subtype - appears amazingly susceptible to the gene.